Skip to main content
Curative Biotechnology, Inc. (CUBT)
OTCMKTS: CUBT · Delayed Price · USD
0.0269
+0.0069 (34.50%)
May 2, 2024, 3:59 PM EDT - Market closed

Curative Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Net Income
-5.6-5.34-4.67
Depreciation & Amortization
0.010.010.01
Share-Based Compensation
0.282.894.3
Other Operating Activities
1.060.10.03
Operating Cash Flow
-4.26-2.34-0.33
Capital Expenditures
--0.01-
Investing Cash Flow
--0.01-
Common Stock Issued
0.121.57-
Other Financing Activities
0.65-0.080.39
Financing Cash Flow
0.761.490.39
Net Cash Flow
-3.49-0.860.05
Free Cash Flow
-1.61-1.63-0.22
Free Cash Flow Per Share
-0.00-0.48-0.07